GRACE

Generalized Risk Adjusted Cost-Effectiveness (GRACE)

Valuing Patient Perspective

Schaeffer Scholars have developed a patient-centric cost-effectiveness model that provides a more effective means of calculating the value of care.

Featured Article

A New Healthcare Valuation Model That Puts Patients First: Generalized Risk Adjusted Cost-Effectiveness (GRACE)

By recognizing that health is worth more to those who have less, GRACE provides a more equitable approach to value assessment and healthcare investments.

Drug Pricing

Experts: Darius Lakdawalla, Stephanie Hedt, Barry Liden

Read: A New Healthcare Valuation Model That Puts Patients First: Generalized Risk Adjusted Cost-Effectiveness (GRACE)

Top Stories View All

News

Why Do Americans Pay More for Prescription Drugs?

Senior Scholar Darius Lakdawalla explains the global economics of prescription drug pricing and outlines a better alternative to President Trump's most-favored-nation executive order.